John Puisis is the founder of Cour Pharmaceuticals Development. Cour Pharmaceuticals Development has raised $135M in total funding. Latest round: Series A.
John J. Puisis founded Cour Pharmaceuticals Development in 2014. The Skokie, Illinois-based biotechnology company develops antigen-specific immunotherapies using polymer nanoparticles for autoimmune diseases like myasthenia gravis and celiac disease. The clinical-stage firm aims to create disease-modifying treatments. Cour Pharmaceuticals Development has raised $135 million across two funding rounds, including a $105 million Series A in January 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library